These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7821134)

  • 1. Glycemic control in a sample of black and white clinic patients with NIDDM.
    Weatherspoon LJ; Kumanyika SK; Ludlow R; Schatz D
    Diabetes Care; 1994 Oct; 17(10):1148-53. PubMed ID: 7821134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intakes by levels of glycemic control for black and white adults with non-insulin dependent diabetes mellitus (NIDDM).
    Bell RA; Summerson JH; Konen JC
    J Am Coll Nutr; 1995 Apr; 14(2):144-51. PubMed ID: 7790688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
    Harris MI; Eastman RC; Cowie CC; Flegal KM; Eberhardt MS
    Diabetes Care; 1999 Mar; 22(3):403-8. PubMed ID: 10097918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
    Agrawal L; Emanuele NV; Abraira C; Henderson WG; Levin SR; Sawin CT; Silbert CK; Nuttall FQ; Comstock JP; Colwell JA
    Diabetes Care; 1998 Apr; 21(4):510-5. PubMed ID: 9571333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pharmaceutical care model on diabetes management.
    Jaber LA; Halapy H; Fernet M; Tummalapalli S; Diwakaran H
    Ann Pharmacother; 1996 Mar; 30(3):238-43. PubMed ID: 8833557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects.
    Banerji MA; Chaiken RL; Lebovitz HE
    Diabetes; 1996 Mar; 45(3):337-41. PubMed ID: 8593939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes in urban African-Americans. IX. Provider adherence to management protocols.
    el-Kebbi IM; Ziemer DC; Musey VC; Gallina DL; Bernard AM; Phillips LS
    Diabetes Care; 1997 May; 20(5):698-703. PubMed ID: 9135929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for metabolic control problems in minority youth with diabetes.
    Delamater AM; Shaw KH; Applegate EB; Pratt IA; Eidson M; Lancelotta GX; Gonzalez-Mendoza L; Richton S
    Diabetes Care; 1999 May; 22(5):700-5. PubMed ID: 10332669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004.
    Suh DC; Choi IS; Plauschinat C; Kwon J; Baron M
    J Diabetes Complications; 2010; 24(6):382-91. PubMed ID: 19716320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic disparities in glycemic control among rural older adults with type 2 diabetes.
    Quandt SA; Bell RA; Snively BM; Smith SL; Stafford JM; Wetmore LK; Arcury TA
    Ethn Dis; 2005; 15(4):656-63. PubMed ID: 16259490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in spatial patterns for poor glycemic control in the Southeastern United States.
    Walker RJ; Neelon B; Davis M; Egede LE
    Ann Epidemiol; 2018 Mar; 28(3):153-159. PubMed ID: 29398299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.
    Shan S; Gu L; Lou Q; Ouyang X; Yu Y; Wu H; Bian R
    Clin Exp Med; 2017 Feb; 17(1):79-84. PubMed ID: 26695015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
    Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen MR
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.